+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Bacterial Pneumonia - Global Strategic Business Report - Product Thumbnail Image

Bacterial Pneumonia - Global Strategic Business Report

  • Report
  • November 2026
  • 455 Pages
  • Global
From
From
Athlete's Foot Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Athlete's Foot Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
From
Carbapenem - Global Strategic Business Report 2026 - Product Thumbnail Image

Carbapenem - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 383 Pages
  • Global
From
Peptide Antibiotics - Global Strategic Business Report 2026 - Product Thumbnail Image

Peptide Antibiotics - Global Strategic Business Report 2026

  • Report
  • November 2026
  • 381 Pages
  • Global
From
Nanomedicine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Nanomedicine Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
From
Breast Cancer Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Breast Cancer Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator